Agilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Agilent Technologies is acquiring Canadian CDMO BIOVECTRA for $925 million to strengthen its biopharma solutions, expand services, and enhance expertise in areas like ADCs and HPAPIs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing